BAX and colonic neoplasm: However, the overall inhibitory effects of 17-AAG on bulk tumor growth were comparable in the BAX+/− and BAX−/− HCT116 colon cancer models, indicating that apoptosis induction is not limiting in the in vivo solid tumor setting and that antiproliferative effects likely dominate the therapeutic response.